Improvement in performance status after erythropoietin treatment in lung cancer patients undergoing concurrent chemoradiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 1, 2003, Pages 116-124

  Casas, Francesc ^a   Viñolas, Núria ^a   Ferrer, Ferran ^b   Farrús, Blanca ^a   Gimferrer, Josep Maria ^a   Agustí, Carles ^a   Belda, Josep ^a   Luburich, Patricio ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL DE L ESPERANÇA   (Spain)

Author keywords

Anemia; Chemoradiation; Erythropoietin; Karnofsky performance status score; Lung cancer

Indexed keywords

BIOLOGICAL ORGANS; CHEMOTHERAPY; HEMOGLOBIN; RADIOTHERAPY; TUMORS;

LUNG CANCERS;

PATIENT TREATMENT;

CISPLATIN; ERYTHROPOIETIN; GEMCITABINE; HEMOGLOBIN; IFOSFAMIDE; NAVELBINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PHASE 2 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; COMBINED MODALITY THERAPY; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMOGLOBINS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVAL RATE;

EID: 0346668258     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)03823-3     Document Type: Article

References (31)

1. Cella D. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale A new tool for the assessment of outcomes in cancer anemia and fatigue . Semin Hematol. 34:1997;13-19.
2. Spivak J.L. Cancer-related anemia Its causes and characteristics . Semin Oncol. 21:1994;3-8.
3. Walker R.H. Special report Transfusion risks . Am J Clin Pathol. 88:1987;374-378.
4. Brunson M.E., Alexander J.W. Mechanisms of transfusion-induced immunosuppression. Transfusion. 30:1990;651-658.
5. Francis D.M. Relationship between blood transfusion and tumor behavior. Br J Surg. 78:1991;1420-1428.
6. Henke M., Guttenberger R., Barke A., et al. Erythropoietin for patients undergoing radiotherapy A pilot study . Radiother Oncol. 50:1999;185-190.
7. Demetri G.D., Kris M., Wade J., et al. Quality-of-life benefit in chemotherapy patients treated with epoetin Alfa is independent of disease response or tumor type Results from a prospective community oncology group . J Clin Oncol. 16:1998;3412-3425.
8. Vijayakumar S., Roach M., Wara W., et al. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy Preliminary results of a randomized, open-labeled, phase II trial . Int J Radiat Oncol Biol Phys. 26:1993;721-729.
9. Ludwig H., Sundal E., Pecherstorfer M., et al. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy. Cancer. 76:1995;2319-2329.
10. Wittes R.E. Manual of oncologic therapeutics 1991/1992. 1991;449-450 JB Lippincott, Philadelphia.
11. Karnofsky D.A., Abelman W.H., Craver L.F., et al. The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer. 1:1948;634-656.
12. Conill C., Verger E., Salamero M. Performance status assessment in cancer patients. Cancer. 65:1990;1864-1866.
13. Emami B., Perez C.A., Herskovich A., et al. Phase I/II study of treatment of locally advanced (T3T4) non-oat cell lung cancer with high dose radiotherapy (rapid fractionation). Int J Radiat Oncol Biol Phys. 15:1988;1021-1025.
14. Turrisi A.T., Glover D.J., Mason B.A. A preliminary report Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited stage small cell lung cancer . Int J Radiat Oncol Biol Phys. 15:1988;183-187.
15. Godfrey K. Statistics in practice Comparing the means of several groups . N Engl J Med. 313:1985;1450-1456.
16. Jennings D.E. Judging inference adequacy in logistic regression. J Am Stat Assoc. 8:1986;471-476.
17. Kaplan E.L., Meier P. Non parametric estimation for incomplete observation. J Am Stat Assoc. 53:1958;457-481.
18. Mantel N., Hanzel W. Statistical aspects the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 22:1959;719-748.
19. Cox D.R. Regression models and life tables. J R Stat Soc Ser. B34:1972;187-220.
20. Glaspy J., Bukowski R., Steinberg D., et al. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. J Clin Oncol. 15:1997;1218-1234.
21. Dunphy F.R., Harrison B.R., Dunleavy T.L., et al. Erythropoietin reduces anemia and transfusions A randomized trial with or without erythropoietin during chemotherapy . Cancer. 86:1999;1362-1367.
22. Thatcher N., De Campos E.S., Bell D.R., et al. Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer. Br J Cancer. 80:1999;396-402.
23. Levine E.A., Laborde C., Hambrick E., et al. Influence of erythropoietin on transfusion requirements in patients receiving preoperative chemoradiotherapy for rectal cancer. Dis Colon Rectum. 42:1999;1065-1069.
24. Glaser C.M., Millesi W., Kornek G.V., et al. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys. 50:2001;705-715.
25. Obermair A., Cheuk R., Horwood K., et al. Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma Preliminary results . Cancer. 92:2001;903-908.
26. Clinical practice guidelines for the treatment of unresectable non-small-cell-lung cancer adopted on May 16 by the American Society of Clinical Oncology. J Clin Oncol. 15:1997;2996-3018.
27. Chemotherapy in non-small cell lung cancer A meta-analysis using updated data on individual patients from 52 randomised clinical trials . BMJ. 311:1995;899-909.
28. Albain K.S., Crowley J.J., LeBlanc M., et al. Survival determinants in extensive stage non-small cell lung cancer The Southwest Oncology Group experience . J Clin Oncol. 9:1991;1618-1626.
29. Caro J.J., Salas M., Ward A., et al. Anemia as an independent prognostic factor for survival in patients with cancer A systematic, quantitative review . Cancer. 91:2001;2214-2221.
30. Turrisi A.T. III, Kim K., Blum R., et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 340:1999;265-271.
31. Izaks G.J., Westendorp R.G., Knook D.L. The definition of anemia in older persons. JAMA. 281:1999;1714-1717.